Aironax Pharmaceuticals Private Limited
Pharmaceutical company specializing in manufacturing and distributing drugs and pharmaceuticals.
2019 | Vadodara, Gujarat (India) | Active
Aironax Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 20.00 K
- Company Age 6 Year, 17 Days
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 16.08%
- Profit Growth 30.50%
- Ebitda 1149.15%
- Net Worth 76.66%
- Total Assets 34.86%
About Aironax Pharmaceuticals
Aironax Pharmaceuticals Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 March 2019 (Six years 17 days old ). Its registered office is in Vadodara, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 20.00 K , as per Ministry of Corporate Affairs (MCA) records.
Vivek Shrivastav, Vijay Srivastava, and Jaya Sriwastava serve as directors at the Company.
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24239GJ2019PTC107343
- Company No.
107343
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Mar 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Pharma
Aironax Pharmaceuticals Private Limited
Explore comprehensive data for Aironax Pharmaceuticals Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Aironax Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vivek Shrivastav  | Director | 29-Mar-2019 | Current |
| Vijay Srivastava | Director | 29-Mar-2019 | Current |
| Jaya Sriwastava | Additional Director | 20-Jun-2019 | Current |
Financial Performance of Aironax Pharmaceuticals.
Aironax Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 16.08% increase. The company also saw a substantial improvement in profitability, with a 30.5% increase in profit. The company's net worth Soared by an impressive increase of 76.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aironax Pharmaceuticals?
Unlock access to Aironax Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Uvmax Laboratories Private Limited
Vijay Srivastava is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aironax Pharmaceuticals?
Unlock and access historical data on people associated with Aironax Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aironax Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aironax Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Aironax Pharmaceuticals
Recent activity within the organization
- Annual General Meeting
Aironax Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Aironax Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.
- Director Appointment
Jaya Rani Sriwastava was appointed as a Additional Director was appointed as a Additional Director on 20 Jun 2019 & has been associated with this company since 5 years 9 months .
- Director Appointment
Vivek Shrivastav was appointed as a Director was appointed as a Director on 29 Mar 2019 & has been associated with this company since 6 years 17 days .
- Director Appointment
Vijay Kumar Srivastava was appointed as a Director was appointed as a Director on 29 Mar 2019 & has been associated with this company since 6 years 17 days .
- Company Incorporation
Aironax Pharmaceuticals Private Limited was registered on 29 Mar 2019 with Roc Ahmedabad & aged 6 years 17 days as per MCA records.
Frequently asked questions
What is the Incorporation or founding date of Aironax Pharmaceuticals Private Limited?
Aironax Pharmaceuticals Private Limited was incorporated on 29 Mar 2019.
What is authorized share capital and paid-up capital of Aironax Pharmaceuticals Private Limited?
The authorized share capital of Aironax Pharmaceuticals Private Limited is ₹ 0.10 M and paid-up capital is ₹ 20.00 K .
Who are the current board members & directors of Aironax Pharmaceuticals Private Limited?
Currently 3 directors are associated with Aironax Pharmaceuticals Private Limited.
- Vivek Shrivastav
- Vijay Kumar Srivastava
- Jaya Rani Sriwastava
What is the registered address of Aironax Pharmaceuticals Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Aironax Pharmaceuticals Private Limited is E-402 The Imperia B.H Yash Complex Gotri Rd Village -, Taluka India, Vadodara, Gujarat, 390021.
What is the corporate identification number (CIN) and company number of Aironax Pharmaceuticals Private Limited?
The corporate identification number (CIN) of Aironax Pharmaceuticals Private Limited is U24239GJ2019PTC107343 and the company number is 107343 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Aironax Pharmaceuticals Private Limited?
According to the financial reports for the fiscal year 2022, the revenue trend for Aironax Pharmaceuticals Private Limited has risen by 16.08%.
What change has been observed in the net worth of Aironax Pharmaceuticals Private Limited, and by what percentage?
The financial reports for the fiscal year 2022 indicates that The net worth of Aironax Pharmaceuticals Private Limited has experienced an upsurge of 76.66%.
When was the last Balance Sheet of Aironax Pharmaceuticals Private Limited filed with the ROC?
The most recent Balance Sheet for Aironax Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records